Inaugural Message from Editor-in-Chief

Abstract

There could not possibly be a better or more appropriate time to introduce the journal Futuristic Biotechnology (FBT) given the extraordinary advancements made over the past few decades in science and medicine. We have had the good fortune to watch as numerous scientific and medical advancements have been combined to push the boundaries of disease detection and treatment that can affect any part of the body. As a result, numerous cutting-edge therapeutic approaches are currently being developed to address diseases for which there are few effective treatments. Although at first glance these therapeutic approaches seem disparate, closer examination reveals that they all rely on a "shared signalling platform" that is closely linked through biological pathways and has a major impact on patient clinical outcomes. It is evident that cellular and genetic targets have a straightforward effect on numerous disease entities. For many disorders, the conversion of these pathways into useful clinical treatments can be fruitful. FBT was designed with this notion in mind. FBT is an open access, peer-reviewed international journal that publishes broad-spectrum researches with close connection to experimental activity related to biology and biotechnology. FBT is intended for exploring the molecular mechanisms that support key biological processes in biochemistry, cellular biosciences, molecular biology, plant biotechnology, genetic engineering, nanotechnology, regenerative medicine and bioinformatics. Furthermore, it also covers topics related to immunology, antibody production, protein purification studies, primer synthesis, DNA sequencing, production of transgenic animal models, insect resistant crop varieties and edible and ornamental plant varieties. FBT will give the scientific and medical communities an international venue to translate basic and clinical research investigations into clinical therapeutics, as well as to report on prognostics, new therapeutic approaches, and the development of biomarkers. As original research papers, review articles, clinical studies, expert opinion, systematic reviews, meta-analysis, commentaries, and letters to the editor, FBT will provide a variety of platforms for authors to share their ideas and discoveries. In the end, FBT will encourage a thorough, impartial, and helpful appraisal of every paper submitted. All authors will be able to track the development of their papers throughout the phases of evaluation, copyediting, and publication because articles will be processed in a very timely manner. With the debut of FBT, we are incredibly enthusiastic and certain that the journal will significantly fill a gap in the reporting of recent scientific and medical advancements. FBT will act as a global platform for the highest level of scholarship in the scientific and clinical sectors to convert ground-breaking "bench to bedside" innovations into effective treatment procedures. On behalf of the Editorial Team and the Editorial Board, welcome to FBT!